NCT04841629View on ClinicalTrials.gov

Perception & Acceptability of a Cervical Cancer Prevention Prebiotic Device

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 24, 2022

Primary Completion Date

November 28, 2022

Study Completion Date

November 28, 2022

Conditions
Sensory Perceptual CharacteristicsUser Acceptability of Gel Delivery System
Interventions
OTHER

PreBioGyn Gel

Cellulose-based prebiotic gel developed to optimize vaginal health and reduce the risk of cervical cancer in women.

OTHER

Trimosan Gel

Carbomer-based gel

OTHER

RepHresh Gel

Carbomer-based gel

Trial Locations (2)

02215

Brigham and Women'S Hospital, Boston

00936

University of Puerto Rico Medical Sciences, San Juan

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

University of Puerto Rico

OTHER

lead

Glyciome, LLC

INDUSTRY